Autologous CD34+ Hematopoietic Stem Cells Transduced ex Vivo With Elongation Factor 1 Alpha Shortened (EFS) Lentiviral Vector Encoding for the Human ADA Gene
Clinical trial NCT01852071 · COMPLETED
Trial details
- NCT number
- NCT01852071
- Sponsor
- University of California, Los Angeles
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-08-02
- Primary completion
- 2018-08-27
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.